Arm Holdings CEO Rene Haas said artificial intelligence could help cure cancer within our lifetime by solving biological modeling problems that remain too complex for humans and current computers. In a BBC interview published on Tuesday, identified in the existing record as September 7, 2026, Haas said AI could accelerate drug development and testing, but warned that chip shortages are constraining the expansion of data-center infrastructure. He described the semiconductor market as absolutely supply-constrained and said more factories are needed before increasingly large data centers, including potential space-based facilities, can be built. Generate Biomedicines said drug-discovery systems require large numbers of GPUs, proprietary biological data and extensive experimentation. Bristol Myers Squibb has deployed an NVIDIA AI system for research, including cancer. Haas said Arm technology is used in about half of AI data centers worldwide, while demand for Arm’s AGI chip developed with Meta has exceeded $2 billion since launch. Arm technology has appeared in more than 350 billion chips, and Haas expects data centers to become its largest business segment.